Celltrion Gets FDA Nod For Subcutaneous Infliximab

Zymfentra, Marketed Globally As Remsima SC, Receives Approval In US

 
• By David Wallace
  
Sign outside of FDA's headquarters in White Oak, MD
Celltrion has received FDA approval for its subcutaneous infliximab • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products